Edward M. Kaye
2015 - Sarepta Therapeutics
In 2015, Edward M. Kaye earned a total compensation of $4.4M as President and Chief Executive Officer at Sarepta Therapeutics, a 158% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $249,704 |
|---|---|
| Option Awards | $1,694,678 |
| Salary | $494,585 |
| Stock Awards | $1,939,532 |
| Other | $18,197 |
| Total | $4,396,696 |
Kaye received $1.9M in stock awards, accounting for 44% of the total pay in 2015.
Kaye also received $249.7K in non-equity incentive plan, $1.7M in option awards, $494.6K in salary and $18.2K in other compensation.
Rankings
In 2015, Edward M. Kaye's compensation ranked 1,921st out of 13,638 executives tracked by ExecPay. In other words, Kaye earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,921 out of 13,638 | 86th |
Division Manufacturing | 689 out of 5,187 | 87th |
Major group Chemicals And Allied Products | 250 out of 1,857 | 87th |
Industry group Drugs | 195 out of 1,531 | 87th |
Industry Pharmaceutical Preparations | 158 out of 1,179 | 87th |
Source: SEC filing on April 27, 2017.
Kaye's colleagues
We found four more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2015.